-
Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?
-
Whats the impact of concomitant medications on combined oral contraceptives (OCs)?
-
Enter abstracts for ARHP annual conference; New payment options announced for Mirena
-
Family planning clinicians have found their care of postmenopausal women has changed dramatically since the July 2002 cessation of the estrogen/progestin arm of the Womens Health Initiative (WHI). The estrogen/progestin arm of the landmark study was halted after findings showed that the overall health risk, particularly of cardiovascular disease and breast cancer, from taking estrogens with progestin was greater than the benefits of lowering the risk of colon cancer and bone fractures.
-
Check out the following Internet resources for more information on hormone therapy.
-
If the number of men on your patient rosters is low, take a look at the approach used by Planned Parenthood of San Antonio and South Central Texas. In the first year of its marketing initiative, the number of its male patients nearly doubled from 2% to 3.7% of total patients served.
-
The Food and Drug Administration (FDA) is proposing a labeling change for over-the-counter vaginal contraceptives containing N-9. The new labeling, when approved, will help users understand that the use of such products can increase vaginal irritation, which actually may heighten the possibility of acquiring the AIDS virus and other STDs from infected partners.
-
Whats the current consensus when it comes to chlamydia screening for adolescents? Take a look at national public health guidelines to help direct you in your practice.
-
Mounting federal deficits coupled with an administration that favors abstinence promotion over contraception means that funding for the Title X family planning program is likely to remain stagnant in the coming years. President Bush sought no additional funding for the program during his first two years in office, and funding increases during the late 1990s did little more than keep pace with inflation.
-
What is your practice when it comes to routinely screening teen-age girls for chlamydia? If you arent performing such testing, you are missing a prime opportunity to reduce the most commonly reported sexually transmitted disease (STD) in the United States.
